The government should use AI to make insurance prior authorization decisions, and it should do so for the same reason governments exist at all: to impose order, accountability, and equity on systems that private fragmentation has left slow, inconsistent, and unfair.
Start with the concrete policy at issue. A government pilot program is testing AI for insurance coverage decisions, specifically in prior authorization. Prior authorization is the process in which an insurer must approve a medical treatment before it is provided. In practice, this process is one of the least defensible administrative chokepoints in American healthcare. It delays care, burdens physicians and hospitals with paperwork, and subjects patients to a maze of insurer-specific rules that are often difficult to understand and harder to challenge.
The stakes are therefore immediate. If AI is used badly in prior authorization, patients could face automated denials with inadequate recourse. If AI is used well, routine approvals could move quickly, providers could spend less time on phone calls and forms, and human reviewers could concentrate on the difficult cases that actually require judgment. The policy choice is not between a pristine human system and a dangerous machine system. It is between the current fragmented prior authorization regime, which is already opaque and often arbitrary, and a publicly governed AI system that can be designed for consistency, auditability, and measurable public outcomes.
The strongest objection deserves to be stated plainly. Critics argue that using AI for prior authorization could create a black box that makes life-changing health coverage decisions with less transparency than a human reviewer. They warn, reasonably, that an algorithm trained on biased historical data could scale denial patterns rather than correct them. They also argue that government involvement does not automatically solve the problem. A state agency can be captured, vendors can oversell, and a system built for speed can become a machine for faster refusals.
Those are serious concerns, and any responsible defense of government AI in insurance coverage decisions must concede them. There is no virtue in pretending that software is neutral because it is software. There is no reason to romanticize bureaucracy merely because it is public. And there is certainly no public interest in replacing one form of opaque gatekeeping with another.
But these objections still fail to defeat the case for government use of AI in prior authorization, because they misidentify the baseline. The baseline is not careful, individualized, transparent medical review. The baseline is a disjointed system in which each insurer sets its own criteria, applies them through its own processes, and imposes its own delays on patients and providers. This is already a black box, only multiplied across the market. It is already automated in parts, scripted in others, and insulated from meaningful public scrutiny almost everywhere. Fragmentation does not protect patients. It merely distributes the same dysfunction across many offices.
That matters because standardization is not the enemy here. Standardization is the remedy. Prior authorization rules should not vary wildly because one patient is enrolled in one plan and another patient in a different one. A government-led AI system can apply common, evidence-based criteria across cases, identify routine approvals quickly, and flag unusual or high-risk cases for human review. In other words, AI should not be imagined as a robotic sovereign replacing medicine. It should be treated as administrative infrastructure, one that makes a public process legible, consistent, and scalable.
This is where the government has an advantage that private insurers do not. The state can define success in terms broader than claims suppression or administrative savings. It can measure approval rates, reversal rates on appeal, time to decision, disparities across demographic groups, provider burden, and downstream health outcomes. It can require logs, explanations, appeals pathways, and external audits. It can publish aggregate performance metrics. It can adjust the model when patterns show bias or excessive denials. Private actors tend to externalize those costs. Public institutions, when properly directed, can internalize them.
Critics often say the bottleneck is not technical but intentional, that prior authorization exists to delay or deny care, and that AI will simply accelerate that function. This criticism is powerful against insurers acting alone. It is less persuasive against a government pilot whose very purpose can be to redesign the process around public objectives. If a public AI system is instructed to prioritize rapid approval for standard treatments that meet clinical guidelines, then automation becomes a tool for reducing denial friction, not multiplying it. The point of state intervention is precisely to change the incentive structure.
Nor is the answer to abandon technology and hope human discretion saves us. Human reviewers are not inherently more just than algorithmic systems. They are expensive, inconsistent, overworked, and often bound by the same rigid coverage rules. A nurse or contractor clicking through insurer protocols is not exercising unlimited medical wisdom. Much of prior authorization is repetitive document matching against policy criteria. That is exactly the sort of administrative work AI can handle well, if the public sector defines guardrails correctly.
The right design principle is simple: automate the routine, escalate the consequential. Low-risk, guideline-concordant requests should move fast. Borderline, novel, or high-severity cases should receive human review. Every denial should be explainable in plain language. Every patient and provider should have a clear appeal route. Every model should be monitored for disparate impact and clinical error. None of these safeguards argues against government use of AI. They are the conditions under which government should use it.
Some opponents suggest a deeper objection, that centralizing prior authorization in public AI creates a single point of failure. But the current system is not resilient merely because it is decentralized. It is redundant in the worst sense, many separate bureaucracies reproducing the same waste, opacity, and procedural burden. A publicly accountable system can fail, certainly, but it can also be corrected systemwide. That is a virtue. When one insurer behaves badly today, every provider must fight a separate battle. When the government sets the standard, reform can be applied at scale.
The broader principle is unavoidable. Healthcare coverage decisions are not ordinary consumer transactions. They are administrative judgments with life and death implications, imposed in a domain where delay itself is a form of harm. That is exactly where public capacity matters most. If AI is entering prior authorization, it is better for it to enter through a government pilot, with public rules and public obligations, than through a patchwork of proprietary insurer systems hidden from view.
The debate, then, is not whether AI can be dangerous. Of course it can. The debate is who should govern it, to what end, and against what baseline of existing failure. On those questions, centralized public oversight is plainly superior to the status quo of fragmented insurance gatekeeping. The government should use AI to make prior authorization decisions, not because technology is magic, but because the current system is intolerable, and only coordinated state action can turn automation into a tool of equity rather than exclusion.